Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honghe Pharmaceutical, specifically Sichuan Honghe Pharmaceutical Co., Ltd., is a Chinese pharmaceutical enterprise based in Chengdu that specializes in the research, development, and manufacturing of traditional Chinese medicine (TCM) and chemical drugs. The company is primarily recognized for its large-scale production of injectable TCM formulations, which are widely used in clinical settings across China for cardiovascular and cerebrovascular conditions. Its product portfolio includes treatments for thrombosis, inflammatory diseases, and respiratory tract infections. Operating with Good Manufacturing Practice (GMP) certified facilities, Honghe maintains a significant presence in the domestic Chinese hospital market. The company continues to modernize ancient TCM formulas using contemporary extraction and purification technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Honghe Pharmaceutical.